Rising stock prices and some positive clinical trial results have been encouraging recent signs for the biotech industry. In addition, public offerings were up, leading a number of observers to believe that the IPO window may be opening. Do you believe that the sector’s future has started to look brighter?
Do you think the bioindustry has begun to turn the corner in terms of financing opportunities?
Too early to tell